INSEAD Day 4 - 728x90

Borouge okays $656m dividend

The company said dividend reflects its resilience

DEWA posts record H1 profit

Revenue reaches record $4.04 billion.

Tabreed H1 revenue $308m

Blurb: Profit reaches $52 million in H1

ADNOC L&S to expand fleet

It will acquire 11 carriers for $1.3bn.

Empower profit climbs 16%

Dubai district cooling demand lifts earnings

Riyadh clears Moderna vaccine for people aged between 12 and 17

  • Clinical studies and reports showed the vaccine's effectiveness and safety
  • The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021

Saudi Arabia has approved the use of the Moderna Covid-19 vaccine for people aged between 12 and 17.

According to state news agency SPA the decision of the authority was based on the data provided by the pharmaceutical company, which showed its vaccine had met special regulatory requirements, and included clinical studies and reports showing its effectiveness and safety.

SFDA’s review found that the known and potential benefits of the vaccine on individuals 12 years of age or older outweigh the risks.

The Moderna COVID-19 vaccine was registered in the Kingdom on July 9, 2021 for those aged 17 years and older.